DexCom Inc.

Company Overview

Dexcom Inc. is a prominent medical device company specializing in continuous glucose monitoring (CGM) systems for people with diabetes. Founded in 1999 and headquartered in San Diego, California, Dexcom’s core product line focuses on devices that provide real-time glucose monitoring, primarily for individuals with Type 1 and Type 2 diabetes. The company’s flagship product, the Dexcom G6 CGM system, continuously tracks glucose levels using a small sensor inserted under the skin. It transmits data wirelessly to a smartphone or receiver, allowing users to manage their blood sugar levels more effectively.

Dexcom’s CGM technology eliminates the need for routine fingerstick and provides actionable data that helps patients and healthcare providers optimize diabetes treatment. The G6 system is particularly known for its accuracy, ease of use and integration with other diabetes management technologies, such as insulin pumps. Dexcom also recently introduced the Dexcom G7, which offers a smaller, more discreet sensor with enhanced features, further improving patient comfort and usability. Through ongoing innovation, Dexcom has established itself as a leader in diabetes management, offering life-changing technology to millions of people globally.

Financial Highlights (FY 2024)

Company's Business Segments

• Medical Devices : continuous glucose monitoring, systems for the management of diabetes and metabolic health